Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement components are a group of plasma proteins that play a central role in the innate immune system. They circulate in the blood and tissue fluids, mostly as inactive precursors, and become sequentially activated in response to pathogens or injury. This activation triggers a cascade of proteolytic events known as the complement cascade, which enhances the ability of antibodies and phagocytic cells to clear microbes, promote inflammation, and directly attack pathogen membranes. Deficiencies or dysregulation can lead to increased susceptibility to infections or autoimmune diseases. The main biological roles include opsonization (tagging pathogens for enhanced phagocytosis), chemotaxis & inflammation (recruiting immune cells via anaphylatoxins like C3a/C5a), and direct lysis (formation of MAC leads to cytolysis of bacteria/viruses).
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Components (N/A).